Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide

Cell Death and Disease

Volumn 4, Issue 8, 2013, Pages

  Biasoli, D ^a   Kahn, S A ^a   Cornelio T A ^a   Furtado, M ^a,b   Campanati, L ^a   Chneiweiss, H ^c   Moura Neto, V ^a   Borges, H L ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cancer stem cells; Cell death; Central nervous system tumor; Macroautophagy; Tumor suppressor; VP 16

Indexed keywords

ACRIDINE ORANGE; BECLIN 1; CASPASE 3; ETOPOSIDE; MICROTUBULE ASSOCIATED PROTEIN 1; NESTIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGOSOME; AUTOPHAGY; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOTHESIS; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LYSOSOME; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

APOPTOSIS; AUTOPHAGY; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA BREAKS, DOUBLE-STRANDED; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84882608216     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.283     Document Type: Article

References (58)

1. Alves TR, Lima FR, Kahn SA, Lobo D, Dubois LG, Soletti R et al. Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma. Life Sci 2011; 89: 532-539
2. Lima FR, Kahn SA, Soletti RC, Biasoli D, Alves T, da Fonseca AC et al. Glioblastoma: Therapeutic challenges, what lies ahead. Biochim Biophys Acta 2012; 1826: 338-349
3. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK et al. Malignant glioma: Genetics and biology of a grave matter. Genes Dev 2001; 15: 1311-1333 (Pubitemid 32524640)
4. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK et al. Glioblastoma multiforme: A review of where we have been and where we are going. Expert Opin Investig Drugs 2009; 18: 1061-1083
5. Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin Oncol 2004; 31: 635-644 (Pubitemid 39389014)
6. Cheema TA, Kanai R, Kim GW, Wakimoto H, Passer B, Rabkin SD et al. Enhanced antitumor efficacy of low-dose Etoposide with oncolytic herpes simplex virus in human glioblastoma stem cell xenografts. Clin Cancer Res 2011; 17: 7383-7393
7. Baldwin EL, Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anti-Cancer Agents 2005; 5: 363-372 (Pubitemid 40974810)
8. Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL. The course of etoposideinduced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem 2002; 277: 16547-16552 (Pubitemid 34967670)
9. Xie X, Le L, Fan Y, Lv L, Zhang J. Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition. Autophagy 2012; 8: 1071-1084
10. Abedin MJ, Wang D, McDonnell MA, Lehmann U, Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ 2007; 14: 500-510
11. Crowley LC, Elzinga BM, ÓSullivan GC, McKenna SL. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am J Hematol 2011; 86: 38-47
12. Katayama M, Kawaguchi T, Berger MS, Pieper RO. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 2007; 14: 548-558
13. Guo XL, Li D, Hu F, Song JR, Zhang SS, Deng WJ et al. Targeting autophagy potentiates chemotherapy-induced apoptosis and proliferation inhibition in hepatocarcinoma cells. Cancer Lett 2012; 320: 171-179
14. Li JL, Han SL, Fan X. Modulating autophagy: A strategy for cancer therapy. Chinese J Cancer 2011; 30: 655-668
15. Filippi-Chiela EC, Villodre ES, Zamin LL, Lenz G. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One 2011; 6: E20849
16. Pucer A, Castino R, Mirkovic B, Falnoga I, Slejkovec Z, Isidoro C et al. Differential role of cathepsins B and L in autophagy-Associated cell death induced by arsenic trioxide in U87 human glioblastoma cells. Biol Chem 2010; 391: 519-531
17. Sparkes RS, Murphree AL, Lingua RW, Sparkes MC, Field LL, Funderburk SJ et al. Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science 1983; 219: 971-973 (Pubitemid 13189527)
18. Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer 2008; 8: 671-682
19. Zhu L. Tumour suppressor retinoblastoma protein Rb: A transcriptional regulator. Eur J Cancer 2005; 41: 2415-2427 (Pubitemid 41540619)
20. Knudsen KE, Booth D, Naderi S, Sever-Chroneos Z, Fribourg AF, Hunton IC et al. RB-dependent S-phase response to DNA damage. Mol Cell Biol 2000; 20: 7751-7763
21. Viatour P, Sage J. Newly identified aspects of tumor suppression by RB. Dis Models Mechanisms 2011; 4: 581-585
22. Haas-Kogan DA, Kogan SC, Levi D, Dazin P, T'Ang A, Fung YK et al. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J 1995; 14: 461-472
23. Fattman CL, Delach SM, Dou QP, Johnson DE. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene 2001; 20: 2918-2926 (Pubitemid 33027759)
24. Tan X, Martin SJ, Green DR, Wang JY. Degradation of retinoblastoma protein in tumor necrosis factor-And CD95-induced cell death. J Biol Chem 1997; 272: 9613-9616 (Pubitemid 27171617)
25. Chau BN, Borges HL, Chen TT, Masselli A, Hunton IC, Wang JY. Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol 2002; 4: 757-765 (Pubitemid 35214769)
26. Borges HL, Bird J, Wasson K, Cardiff RD, Varki N, Eckmann L et al. Tumor promotion by caspase-resistant retinoblastoma protein. Proc Natl Acad Sci USA 2005; 102: 15587-15592 (Pubitemid 41528100)
27. Boutillier AL, Trinh E, Loeffler JP. Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis. Oncogene 2000; 19: 2171-2178 (Pubitemid 30307182)
28. Chau BN, Pan CW, Wang JY. Separation of anti-proliferation and anti-Apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domain. PLoS One 2006; 1: E82
29. Knudsen ES, Knudsen KE. Tailoring to RB: Tumour suppressor status and therapeutic response. Nat Rev Cancer 2008; 8: 714-724
30. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-1068
31. Nduom EK, Hadjipanayis CG, Van Meir EG. Glioblastoma cancer stem-like cells: Implications for pathogenesis and treatment. Cancer J 2012; 18: 100-106
32. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-2728
33. Zhuang W, Li B, Long L, Chen L, Huang Q, Liang Z. Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 2011; 129: 2720-2731
34. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522-526
35. 4a) overexpression in malignant cells with wild-Type pRb and p53. Cell Cycle 2010; 9: 3286-3296
36. Faria J, Romao L, Martins S, Alves T, Mendes FA, de Faria GP et al. Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Diff Res Biol Diversity 2006; 74: 562-572 (Pubitemid 44922501)
37. Silvestre DC, Pineda JR, Hoffschir F, Studler JM, Mouthon MA, Pflumio F et al. Alternative lengthening of telomeres in human glioma stem cells. Stem cells 2011; 29: 440-451
38. Galan-Moya EM, Le Guelte A, Lima Fernandes E, Thirant C, Dwyer J, Bidere N et al. Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway. EMBO Rep 2011; 12: 470-476
39. Aeschbacher M, Reinhardt CA, Zbinden G. A rapid cell membrane permeability test using fluorescent dyes and flow cytometry. Cell biology and toxicology 1986; 2: 247-255 (Pubitemid 16010021)
40. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997; 91: 325-334 (Pubitemid 27467963)
41. Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H et al. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 1998; 17: 598-608 (Pubitemid 28045499)
42. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273: 5858-5868 (Pubitemid 28124064)
43. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445-544
44. 3 is a marker for autophagy. Autophagy 2005; 1: 84-91
45. Rose TL, Bonneau L, Der C, Marty-Mazars D, Marty F. Starvation-induced expression of autophagy-related genes in Arabidopsis. Biol Cell 2006; 98: 53-67 (Pubitemid 43056294)
46. Crighton D, Wilkinson S, ÓPrey J, Syed N, Smith P, Harrison PR et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006; 126: 121-134 (Pubitemid 44040988)
47. Valbuena A, Castro-Obregon S, Lazo PA. Downregulation of VRK1 by p53 in response to DNA damage is mediated by the autophagic pathway. PLoS One 2011; 6: E17320
48. Bosco EE, Mayhew CN, Hennigan RF, Sage J, Jacks T, Knudsen ES. RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res 2004; 32: 25-34 (Pubitemid 38228601)
49. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-752 (Pubitemid 47312826)
50. Huang X, Masselli A, Frisch SM, Hunton IC, Jiang Y, Wang JY. Blockade of tumor necrosis factor-induced Bid cleavage by caspase-resistant Rb. J Biol Chem 2007; 282: 29401-29413 (Pubitemid 350043386)
51. Kanematsu S, Uehara N, Miki H, Yoshizawa K, Kawanaka A, Yuri T et al. Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells. Anticancer Res 2010; 30: 3381-3390
52. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117: 326-336 (Pubitemid 46203961)
53. Shimizu S, Takehara T, Hikita H, Kodama T, Tsunematsu H, Miyagi T et al. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma. Int J Cancer 2012; 131: 548-557
54. Rolle K, Nowak S, Wyszko E, Nowak M, Zukiel R, Piestrzeniewicz R et al. Promising human brain tumors therapy with interference RNA intervention (iRNAi). Cancer Biol Ther 2010; 9: 396-406
55. Patru C, Romao L, Varlet P, Coulombel L, Raponi E, Cadusseau J et al. CD133, CD15/ SSEA-1, CD34 or side populations do not resume tumor-initiating properties of long-Term cultured cancer stem cells from human malignant glio-neuronal tumors. BMC Cancer 2010; 10: 66
56. Wang JY, Knudsen ES, Welch PJ. The retinoblastoma tumor suppressor protein. Adv Cancer Res 1994; 64: 25-85 (Pubitemid 24351293)
57. Rasband WS. ImageJ. US National Institutes of Health: Bethesda, MD, USA, 1997. Available from: Http://imagej.nih.gov/ij/.
58. Geisa M, Faustino MG, Carlos J, de Lucena P, Stevens Rehen. Embryonic Stem Cell Counter 2009 Available from http://escc.inf.puc-rio.br/index.html